Reaction

Intestinal Stenosis reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 4,154 reports · 33 co-occurring drugs

As of the last recalculation, Intestinal Stenosis appears in 4,154 FAERS reports alongside 33 co-occurring drug terms. The strongest observed disproportionality signal is VEDOLIZUMAB (PRR 31.8).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Vedolizumab48531.832.0
Azathioprine48631.231.3
Adalimumab2,08028.528.6
Infliximab80622.722.8
Cholestyramine4619.319.3
Mesalamine17516.316.3
Infliximab-Dyyb8715.215.3
Adalimumab-Fkjp11312.512.6
Adalimumab-Aaty11112.012.1
Ustekinumab22411.511.6
Adalimumab-Adaz11110.810.8
Diphenoxylate Hydrochloride And Atropine Sulfate2910.710.7
Mercaptopurine339.69.6
Risankizumab-Rzaa1489.49.4
Hyoscyamine Sulfate168.88.8
Teduglutide228.28.2
Iron947.27.2
Dicyclomine Hydrochloride207.17.1
Metronidazole826.56.5
Ciprofloxacin Hydrochloride And Hydrocortisone276.56.5
Loperamide Hydrochloride And Dimethicone365.75.7
Budesonide655.65.6
Ampicillin95.55.5
Ampicillin Sodium95.55.5
Hydrocortisone Sodium Succinate105.35.3
Upadacitinib855.35.3
Loperamide Hydrochloride384.34.3
Certolizumab Pegol813.53.5
Cortisone Acetate83.33.3
Encorafenib52.52.5
Isotretinoin232.32.3
Apalutamide31.31.3
Guselkumab71.01.0

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.